Woodcock’s to-do list, Maraganore’s takeaways & the Distillery

Plus Emerging Company Spotlight featuring Anocca, AviadoBio and Chroma

On the latest BioCentury This Week podcast, BioCentury’s editors discuss the initiatives Acting FDA Commissioner Janet Woodcock has launched to modernize the agency’s organizational structure and finances, and the status of President Joe Biden’s nomination of Robert Califf to fill the agency’s top post. Editor in Chief Simone Fishburn and Washington Editor Steve Usdin examine take-home messages on the state of the biopharma ecosystem from BioCentury’s exit interview with John Maraganore, the outgoing CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), and Senior Editor Karen Tkach Tuzman returns to deliver translational highlights from BioCentury’s Distillery.

In this week’s Emerging Company Spotlight, BioCentury This Week Host Jeff Cranmer features Sweden’s Anocca, which is creating libraries of engineered human cells that enable standardized and automated TCR target discovery and characterization; AviadoBio Ltd., with its “precision microdosing” approach to treating diseases such as frontotemporal dementia and amyotrophic lateral sclerosis; and epigenetic editing company Chroma Medicine Inc., which debuted last month with a $125 million series A round led by Cormorant Asset Management.